Table 2 Objective outcomes on lysine aspirin (LAS) treatment, –Objective scores pre-treatment and at 3 and 12 months
From: Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease
Pre | 3 m | 12 m | |
|---|---|---|---|
NIPF (litres/min) | 145.4 ± 8.7 | 163.3 ± 8.5* | 160.5 ± 15.9 |
Expired NO (ppb) | 13.2 ± 1.64 | 14.9 ± 1.63 | 7.54 ± 0.85* ** |
Nez du Vin | 1.75 ± 0.75 | 2.54 ± 0.80* | 3.13 ± 0.64* |
Nasal NO Right (ppb) | 336.6 ± 32.7 | 347.9 ± 34.2 | 442.23 ± 78.7 |
Nasal NO Left (ppb) | 343.8 ± 36.7 | 331.9 ± 39.3 | 456.4 ± 91.2 |